Astec Lifesciences Ltd.
NSE: ASTEC | BSE: 533138
₹675.80
₹18.60
(2.83%)
As on 15-May-2026IST
Market cap
₹1,508 Cr
Revenue (TTM)
₹448 Cr
P/E Ratio
--
P/B Ratio
3.9
Div. Yield
0 %
Quality Score
1/10
Growth Score
4/10
Valuation Score
2/10
Momentum Score
7/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹-81 Cr
-
ROE
-44.6 %
-
ROCE
-12.6 %
-
Industry P/E
27.76
-
EV/EBITDA
3568.7
-
Debt to Equity
0.1
-
Book Value
₹175.3
-
EPS
₹-37.4
-
Face value
10
-
Shares outstanding
22,282,238
10 Years Aggregate
CFO
₹347.02 Cr
EBITDA
₹594.07 Cr
Net Profit
₹141.52 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Astec Lifesciences
| -4.1 | 6.3 | 6.1 | -0.6 | -20.5 | -11.5 | 10.9 |
|
BSE Commodities
| 8.0 | 6.1 | 4.5 | 15.4 | 18.1 | 11.8 | 16.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Astec Lifesciences
| -27.8 | -7.3 | -37.5 | 22.2 | 11.2 | 195.2 | -13.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Commodities
| 12.5 | 8.1 | 17.5 | 1.2 | 61.5 | 26.1 | -4.6 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Astec Lifesciences
|
675.8 | 1,508.3 | 448.2 | -80.9 | -11.0 | -19.6 | -- | 3.9 |
| 102.9 | 663.1 | 637.8 | 35.3 | 8.3 | 14.3 | 18.8 | 2.1 | |
| 7,100.0 | 20,901.0 | 6,273.5 | 683.0 | 11.3 | 11.2 | 30.8 | 3.4 | |
| 449.9 | 17,975.3 | 20,793.7 | 1,824.5 | 11.2 | 19.3 | 9.2 | 1.7 | |
| 52.1 | 1,322.4 | 2,174.0 | 28.8 | 2.6 | 1.9 | 46 | 0.9 | |
| 161.6 | 3,793.6 | 1,584.5 | 4.7 | 4.5 | 2 | 830.1 | 5.6 | |
| 1,045.9 | 1,279.6 | 1,029.8 | 64.0 | 8.6 | 15.9 | 20 | 3.0 | |
| 263.7 | 5,133.0 | 2,897.0 | 184.0 | 8.4 | 12.1 | 27.9 | 2.5 | |
| 969.0 | 8,752.3 | 5,267.6 | 681.0 | 12.9 | 23.4 | 12.9 | 2.8 | |
| 632.3 | 53,364.2 | 51,839.0 | 2,414.0 | 11.6 | 5.6 | 27.8 | 1.5 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Astec Lifesciences
Astec LifeSciences Limited, together with its subsidiaries, manufactures and sells agrochemical active ingredients and pharmaceutical intermediates in India. The company provides triazole fungicides for use in field crops; foliar treatment for the... control of scab, powdery mildew, shot-hole, blossom blight, and rust; seed treatment for the control of seed and soil-borne diseases in cotton and maize, as well as grains, such as barley, rice, and wheat; post-harvest drench; and food additive and wood preservative. It also provides herbicides, insecticides, and specialty chemical products. The company also exports its products. The company was incorporated in 1994 and is based in Mumbai, India. Astec LifeSciences Limited is a subsidiary of Godrej Agrovet Limited. Read more
-
Incorporated
1994
-
Chairman
Vishal Sharma
-
Managing Director
Burjis Godrej
-
Group
Godrej
-
Headquarters
Mumbai, Maharashtra
-
Website
Looking for more details about Astec Lifesciences Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsUpdates- Grant Of Stock Options
30-Apr-2026Book Closure For 32Nd Annual General Meeting
27-Apr-2026Clarification To BSE Regarding Price Movement
20-Apr-2026Clarification sought from Astec Lifesciences Ltd
17-Apr-2026No News & Announcements are available.
FAQs for Astec Lifesciences
What is the current share price of Astec Lifesciences Ltd Today?
The share price of Astec Lifesciences Ltd is ₹675.80 (NSE) and ₹676.90 (BSE) as of 15-May-2026 IST. Astec Lifesciences Ltd has given a return of -20.51% in the last 3 years.
What is the current PB & PE ratio of Astec Lifesciences Ltd?
Since, TTM earnings of Astec Lifesciences Ltd is negative, P/E ratio is not available.
The P/B ratio of Astec Lifesciences Ltd is 3.86 times as on 15-May-2026, a 28 premium to its peers’ median range of 3.02 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
5.64
|
|
2024
|
0.00
|
5.65
|
|
2023
|
106.02
|
6.47
|
|
2022
|
38.22
|
8.67
|
|
2021
|
30.12
|
6.35
|
What is the 52 Week High and Low of Astec Lifesciences Ltd?
The 52-week high and low of Astec Lifesciences Ltd are Rs 990.82 and Rs 513.40 as of 17-May-2026.
What is the market cap of Astec Lifesciences Ltd?
Astec Lifesciences Ltd has a market capitalisation of ₹ 1,508 Cr as on 15-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Astec Lifesciences Ltd?
Before investing in Astec Lifesciences Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.